Discover our Media


The latest news

Bayer: Challenging third quarter – Group outlook confirmed

Bayer: Solid performance despite COVID-19 impact

Bayer completes the sale of its Animal Health business unit to Elanco

Bayer: Good start to 2020 – activities marked by COVID-19

Bayer strategically and operationally successful

Bayer: Encouraging business performance across all divisions – agreements signed to divest Currenta and Animal Health

Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars

Bayer on track in operational business

Bayer: strong operational start to the year

Bayer increases sales and earnings – leader in agriculture after acquisition

Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability